According to Jubilant Pharmova's latest financial reports the company has a price-to-book ratio of 1.98.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 1.60 | 48.6% |
2022-12-31 | 1.07 | -41.21% |
2021-12-31 | 1.83 | -19.58% |
2020-12-31 | 2.27 | 40.6% |
2019-12-31 | 1.62 | -37.34% |
2018-12-31 | 2.58 | -24.79% |
2017-12-31 | 3.43 | 16.71% |
2016-12-31 | 2.94 | 22.78% |
2015-12-31 | 2.39 | 249.86% |
2014-12-31 | 0.6840 | -17.96% |
2013-12-31 | 0.8337 | -41.48% |
2012-12-31 | 1.42 |